Post by Oliver Bozinov

Neurochirurg, Chefarzt, Professor, Geschäftsleitungsmitglied, Stv. CMO, Präsident der SGNC, Beirat, Mensch

We talk about it for years and now we see some evidence. These are still selected patients but opening of the blood brain barrier is a thing and the right therapy taking advantage of it will come up, maybe it is pembrolizumab. At HOCH Health Ostschweiz we frequently use LITT for over 5 years and I can confirm especially the positive feedback by the patients, they love it.

Post content